Clinical Trials · NCT04228354
A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 28
- Start date
- Jan 2020
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the semaglutide plasma concentration curve from 0 to tz